Start with an open question

Begin with Dorothy’s understanding and emotional response.

“I can understand why you would be worried about an unexpected letter, and I’m sorry it upset you. Can you tell me a bit more about the letter and how you have been feeling, and then perhaps I can help explain why it was sent?”

This allows Dorothy to explain what she read, what she understood and what frightened her.

Time-efficient data gathering

Efficient data gathering should:

• Clarify what the letter said.
• Check the letter content against the kidney results on file.
• Explore Dorothy’s understanding and fears.
• Ask about symptoms of kidney disease or complications.
• Review possible causes and risk factors.
• Review medication, including over-the-counter medicines.
• Explore psychological and social impact.

Avoid turning the consultation into a long checklist before addressing her anxiety.

High-yield questions

Understanding and concerns

• “What did the letter say that worried you most?”
• “What do you understand by kidney disease?”
• “You mentioned dialysis — is that your main worry?”

Symptoms and red flags

• “Have you noticed any changes such as swelling, tiredness, or problems passing urine?”
• “Have you had breathlessness, changes in your urine, confusion or persistent vomiting?”

Risk factors and causes

• “Do you have any family history of kidney problems, diabetes, or autoimmune conditions?”
• “Have you ever been told you have diabetes?”
• “How has your blood pressure been recently?”

Medication review

• “Can you tell me about the medicines you take and if you’re taking anything else, including over-the-counter?”

Explore medicines that may affect kidney function, including relevant non-prescribed medicines.

Lifestyle and support

• “How has receiving this letter affected you day to day?”
• “Do you have someone you can talk to about health worries?”
• “How are you managing at home?”

Functional, psychosocial or contextual assessment

Dorothy’s distress matters clinically because anxiety may affect her ability to understand and follow the plan.

Explore:

• Shock and anxiety after receiving the letter.
• Fear because of her friend’s dialysis experience.
• Any bereavement or previous health fears if raised.
• Living alone.
• Daily activities.
• Support network.
• Coping and need for reassurance.

Explore ideas, concerns and expectations

A useful goal-setting phrase:

“By the end of our conversation, would it be helpful if I could explain what your kidneys are doing now, what this means for your health, and what we can do to keep you well?”

This makes the consultation collaborative and focused.

Recognise and respond to cues

Dorothy is shocked and anxious. She may ask directly whether she will need dialysis.

Respond clearly and empathically:

“I can see this was a real shock for you, and I understand why you might be worried after seeing what your friend went through.”

If she asks about dialysis, pause and answer directly rather than deferring or minimising.

Useful consultation phrases

“Your kidneys are working less well than when you were younger, but they are still working well.”

“If they keep working at this level, they won’t cause you a problem.”

“The reason for the slight worsening is most commonly age and high blood pressure.”

“Think of your kidneys as filters that, over time, may not work quite as efficiently, a bit like how our eyesight or hearing change with age.”

“The good news is it’s stable and there are things we can do together to protect your kidneys.”

Consultation flow and signposting

1. Explore Dorothy’s reaction to the letter.
2. Check the letter against the kidney results on file.
3. Ask about symptoms and red flags.
4. Review medical history, blood pressure and possible diabetes risk.
5. Review medication and over-the-counter drugs.
6. Explore psychological and social impact.
7. Explain CKD stage 3 in plain language.
8. Discuss likely cause and monitoring.
9. Agree prevention, safety-netting and follow-up.
10. Check understanding and offer resources.

Use transitions:

“Thank you for sharing that. Let’s look together at your recent test results and I’ll explain what they mean.”

Summarising and checking understanding

Before management, summarise:

“You received a letter unexpectedly and it made you worry your kidneys might fail like your friend’s. Your tests show your kidneys are working a bit less well than before, but this has been stable. You feel well, and we’ll check urine and other risk factors to make sure we are not missing anything.”

Check understanding:

“I’ve given you a lot of information. What questions do you have?”

This invites questions more effectively than asking, “Do you understand?”

Data gathering self-check

Before moving to management, the trainee should know:

• What the letter said and whether it matches the records.
• Dorothy’s main concern, especially dialysis.
• Whether she has swelling, tiredness, urinary problems or other concerning symptoms.
• Family history of kidney disease, diabetes or autoimmune conditions.
• Current medicines and over-the-counter use.
• Blood pressure history and control.
• Whether diabetes needs consideration.
• Whether urine testing has been done or is needed.
• Psychological impact and support needs.
• Whether she lives alone and how she copes.

Assessment domain mapping

Data gathering

• Understanding of the letter.
• Symptoms and red flags.
• Family history and risk factors.
• Medication and over-the-counter review.
• Psychological impact and support.

Clinical management

• Explaining stable CKD stage 3.
• Monitoring kidney function and urine.
• Blood-pressure control.
• Medication safety and avoiding nephrotoxicity.
• Lifestyle advice and vaccinations.
• Safety-netting and referral thresholds.

Relating to others

• Empathic response to shock.
• Directly addressing dialysis fear.
• Plain-language explanation.
• Checking understanding and offering reassurance.

‍

Prioritised differential diagnosis or clinical reasoning

The likely explanation is:

1. CKD stage 3 secondary to hypertension and age — most likely in a 68-year-old with hypertension and gradual decline in kidney function.

Other possibilities to consider include:

2. CKD from other vascular causes, such as atherosclerosis.
3. Unrecognised diabetic nephropathy, if diabetes is present.
4. Glomerulonephritis or other primary renal disease, less likely without urinary symptoms or family history.
5. Drug-induced nephropathy, if exposed to nephrotoxic drugs.
6. Obstructive uropathy, much less likely without urinary symptoms.

Clinical reasoning script

“The most likely reason your kidneys are not working quite as well is your blood pressure over the years, combined with age-related change. The good news is that your kidney function has been stable, and we can reduce the chance of future problems by monitoring it and keeping your blood pressure well controlled.”

Red flags and risk assessment

Assess for:

• Swelling.
• Breathlessness.
• Change in urine.
• Problems passing urine.
• Confusion.
• Persistent vomiting.
• Significant tiredness.
• Family history suggesting inherited kidney disease.
• Diabetes.
• Autoimmune conditions.
• Nephrotoxic medication exposure.

Also use urine testing to look for additional signs of kidney stress or hidden damage.

“We send urine tests to check for any extra signs of kidney stress or hidden damage, so we don’t miss anything.”

Decision points

Key decisions include:

• Does the letter match Dorothy’s current results?
• Is CKD stable or declining?
• Are there symptoms or features suggesting a secondary cause?
• Are urine tests needed, including uACR?
• Are blood pressure and cardiovascular risk being adequately managed?
• Are any medicines potentially harmful to the kidneys?
• Is nephrology referral needed, or is monitoring appropriate?
• How much reassurance and follow-up does Dorothy need?

Management priority

The management priority is to reassure Dorothy while protecting kidney function through monitoring and modifiable risk-factor control.

The plan should focus on:

• Stability of kidney function.
• Blood-pressure control.
• Urine and blood monitoring.
• Medication safety.
• Lifestyle optimisation.
• Vaccination.
• Clear safety-netting.
• Emotional support where needed.

Management options

1. Ongoing monitoring

Arrange continued monitoring of kidney function with annual blood and urine tests, including:

• uACR.
• eGFR.
• Creatinine.

Explain that monitoring helps detect changes early.

2. Blood-pressure monitoring and control

Discuss regular blood-pressure monitoring and control.

The target is ≤140/90 or as per comorbidities.

Explain that blood-pressure control is one of the best ways to protect kidney function.

3. Medication review

Review medicines for potential nephrotoxicity.

Discuss:

• Avoiding NSAIDs where appropriate.
• Careful use of ACE inhibitors.
• Continuing ACE inhibitors unless contraindications are present.
• Checking drug dosing in CKD using BNF guidance where relevant.

4. Lifestyle optimisation

Discuss practical lifestyle measures:

• Maintain a healthy weight.
• Exercise as tolerated.
• Low salt intake.
• Adequate hydration.
• Avoid over-restricting protein or fluids without dietitian advice.

5. Vaccinations

Discuss vaccination to reduce infection risk, including:

• Annual flu vaccination.
• Pneumococcal vaccination.
• COVID-19 vaccination.

6. Safety-netting symptoms

Explain symptoms requiring prompt review, including:

• Swelling.
• Breathlessness.
• Change in urine.
• Confusion.
• Persistent vomiting.

7. Psychosocial support

Address anxiety and offer support if needed.

Options include:

• Further follow-up discussion.
• Support for emotional wellbeing.
• Signposting to kidney charities if Dorothy wants information or reassurance.

8. Referral if needed

Explain that nephrology referral may be considered if there is:

• Persistent proteinuria.
• Declining eGFR.
• Unclear cause.

At present, referral need is low given stability.

Personalised plan

A personalised plan for Dorothy might include:

• Confirming that CKD stage 3 is stable.
• Explaining that dialysis is very unlikely from the current information.
• Checking urine for uACR.
• Annual blood and urine monitoring.
• Blood-pressure review and control.
• Medication review, including over-the-counter medicines.
• Advice to avoid kidney-harming medicines where appropriate.
• Lifestyle advice focused on achievable changes.
• Clear symptoms that should prompt contact.
• Optional kidney charity information.
• Follow-up if she remains anxious or has questions.

Example phrase:

“Keeping active and making sure your blood pressure is controlled are some of the best ways to protect your kidneys. As you live alone, if you are ever worried, please contact us, particularly if you notice swelling, tiredness, or problems with your urine.”

Shared decision-making

Involve Dorothy by asking:

• “Would it help to go through the results together?”
• “Would you like written information to take away?”
• “Would you prefer a planned follow-up after the urine test?”
• “Would you like information from a kidney charity, or would that feel overwhelming?”

Tailor the approach to what reassures her most.

Safety-netting

Advise Dorothy to contact the practice promptly if she notices:

• Swelling.
• Breathlessness.
• Change in urine.
• Confusion.
• Persistent vomiting.
• Worsening tiredness.
• Problems passing urine.

If she feels very worried after the consultation, encourage her to contact the practice rather than remaining anxious at home.

Documentation points

Document:

• Letter reviewed and matched to kidney results.
• Dorothy’s understanding and concerns.
• Fear of dialysis addressed.
• CKD stage and stability explained.
• Symptoms and red flags assessed.
• Family history and risk factors.
• Medication and over-the-counter review.
• Monitoring plan.
• Blood-pressure advice.
• Lifestyle and vaccination advice.
• Safety-netting.
• Resources offered.

Common unsafe management plans

Avoid:

• Dismissing Dorothy’s worry because CKD is stable.
• Explaining CKD using unexplained eGFR terminology.
• Failing to check the letter against the record.
• Not answering the dialysis concern directly.
• Ignoring medication causes.
• Forgetting urine testing.
• Over-restricting diet or fluids without dietitian advice.
• Not giving clear safety-netting.
• Not offering follow-up or resources if she remains anxious.

Follow-up and coordination with other professionals

Follow-up should include:

• Review of urine results, including uACR.
• Annual blood and urine monitoring.
• Blood-pressure monitoring.
• Medication review.
• Review if kidney function declines, proteinuria persists or cause becomes unclear.
• Reassessment if new symptoms develop.
• Emotional support or kidney charity signposting if wanted.

Learner checkpoint

Have I corrected Dorothy’s misconception about dialysis while still explaining CKD monitoring and kidney protection clearly?

‍

Relevant guidance areas

This includes guidance and resources on:

• Chronic kidney disease diagnosis and monitoring.
• CKD causes and risk-factor modification.
• Drug dosing and medication safety in CKD.
• Patient-centred explanation and reassurance.
• Kidney charity support.

NICE guidance

• NICE CKD Clinical Knowledge Summary.
• NICE Guideline NG203: CKD.

BNF references

• BNF guidance for drug dosing in CKD.

RCGP and SCA resources

Relevant references include MRCGP annual reports and research, and examiner feedback on checking understanding.

Patient information websites

• Kidney Care UK — Living with Kidney Disease.

Relevant research or educational references

• MRCGP annual reports and research.
• Roger Neighbour: Consulting in a Nutshell.
• RCGP examiner feedback, N. Turner.

Key principles to remember

• Start with Dorothy’s understanding and concern about the unexpected letter.
• Check the letter content against the kidney results.
• Explain CKD stage 3 in plain language.
• Address fear of dialysis directly.
• Stable stage 3 CKD is common with age and hypertension.
• Check for symptoms, family history, diabetes and autoimmune disease.
• Review medicines and over-the-counter drugs.
• Use blood and urine monitoring, including uACR.
• Control blood pressure and review cardiovascular risk factors.
• Avoid unnecessary over-restriction of fluids or protein without dietitian advice.
• Safety-net for swelling, breathlessness, urine changes, confusion and persistent vomiting.
• Offer resources and follow-up based on Dorothy’s anxiety and support needs.

Transferable learning for future cases

When patients receive unexpected abnormal results:

• Start with the emotional impact, not the laboratory value.
• Check what the patient has read and understood.
• Use plain language and avoid frightening labels without explanation.
• Address the patient’s worst fear directly.
• Explain what is stable, what needs monitoring and what can be modified.
• Give a written or follow-up plan to reduce anxiety.

Supervisor or examiner lens

A supervisor or examiner is likely to look for:

• Empathic response to shock.
• Clear explanation of CKD stage 3.
• Direct reassurance about dialysis risk based on stability.
• Assessment of symptoms and secondary causes.
• Medication and nephrotoxicity review.
• Evidence-based monitoring plan.
• Blood-pressure and lifestyle management.
• Checking understanding and offering reliable resources.

‍

Final learner takeaway

For stable CKD found unexpectedly, the GP’s task is to translate a frightening label into a clear, reassuring plan: confirm, explain, monitor and protect kidney function.

‍